App-Quantinova.ai

Outcomes of Multi Disciplinary Team Comprehensive Post Hospitalisation Follow Up for 420 COVID 19 Patients

Yasser Noeman Ahmed - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Evaluation of the Air Next spirometer in paediatric cystic fibrosis patients

Natalie Blyth - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Utility of predischarge spirometry in AECOPD discharges

Samir Naik - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Prevalence of altering selected spirometry maneuvers in asthma clinical trials

Carl D. Mottram - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Evaluation of patient attendance to respiratory physiology in the midst of the COVID-19 Pandemic

Charlotte Hurst - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Do bacterial/viral filters impact quality assurance verification of ultrasonic spirometers?

Lucy Robertson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Real-world application of Spirometry Quality Control Deep-Learning Algorithm

Sanja Stanojevic - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

A novel ambulatory management pathway for Cobid-19 patients using home oximetry

Shashank Sharma - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The efficacy and safety of colistimethate sodium delivered via the I-neb in bronchiectasis: the PROMIS-I randomized controlled trial

Charles S Haworth - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

Colistimethate sodium

Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE)

Carlos Fernandez - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

Elaszym

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Sanjay Ramakrishnan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Budesonide

An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19

Bronwen Connolly - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute respiratory failure

N/A

Association between age, deprivation and ethnicity with COVID-19 hospitalisation and mortality

Danyal Jajbhay - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Impact of COVID-19 on patients with chronic lung disease

Etel Etel - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Blood lactate level in patients with severe COVID-19: Does it have any added value?

Raghda Hassan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Predicting mortality in patients admitted to hospital with COVID-19 infection: a retrospective analysis of data for a District General Hospital in the United Kingdom

Colette Davidson - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Impact of bacterial co-infection with COVID-19 on morbidity and mortality

Scott Waring - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Common symptoms in hospitalized COVID-19 patients by age, severity and survival outcome A literature review

Eileen Han - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Outcomes of level 1 Covid-19 inpatients at six months

Jonathan Bates-Powell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Another aspect of COVID pandemic: where has all the Flu gone?

Taya Chapman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Filters

45280 Abstracts